Brevan Howard Capital Management LP Ultragenyx Pharmaceutical Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 16,241 shares of RARE stock, worth $649,640. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,241Holding current value
$649,640% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.5MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$224 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$205 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$167 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$123 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.8B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...